Allergy Research Group releases Joint-Skin with Salmon Collagen and Proteoglycans

December 03, 2018

Alameda, CA – FOR IMMEDIATE RELEASE: Allergy Research Group continues its heritage of bringing innovative nutritional supplements to the professional market with our newest product, Joint-Skin with Salmon Collagen and Proteoglycans.

Joint-Skin with Salmon Collagen and Proteoglycans contains SCP-II® salmon nasal cartilage, which provides 6.5 mg of undenatured Type II collagen and 5 mg of undenatured proteoglycans per capsule. SCP-II® is obtained from salmon (Oncorhynchus keta) nasal cartilage that is naturally extracted from sustainably caught wild salmon in Japan. It contains no carriers, is non-GMO and non-irradiated. Clinical studies have shown that low doses of Type II collagen and proteoglycans can support improved joint function, mobility, and reduce discomfort.* Proteoglycans have been shown to help increase skin and connective tissue hydration, supporting youthful skin tone, elasticity, and appearance.*

To learn more about this product visit https://www.allergyresearchgroup.com/joint-skin, or call our customer service team at 1-800-545-9960, extension 2.

CONTACT:
Dan Mallar, National Sales Director
dan.mallar@allergyresearchgroup.com

SCP-II® is a registered trademark of Guzen Development, Inc.

*This statement has not been evaluated by the U.S. Food and Drug administration. The product is not intended to diagnose, treat, cure, or prevent any disease.